molecular physiology and biophysics
Dec. 5, 2019—Poorly functioning AMPARs have been linked to a wide range of neurological and psychiatric disorders including seizures, Alzheimer’s disease, major depression and autism spectrum disorder. Understanding how AMPARs are formed and operate is essential for the rational design of pharmacological compounds that, by tuning AMPAR activity up or down, could improve treatment of these conditions.
Sep. 29, 2019—Nancy Carrasco, new chair of the Department of Molecular Physiology and Biophysics and originally from Mexico City, knows how enriching an experience living abroad can be.
May. 30, 2019—Vanderbilt University researchers have discovered how a protein pump distinguishes between chemicals that it will expel from a cell and inhibitors that block its action. The new findings could guide the development of more efficient inhibitors to prevent cancer cell resistance to chemotherapy.
Apr. 12, 2018—Brian Kobilka, MD, who received the 2012 Nobel Prize in Chemistry for his studies of G protein-coupled receptors (GPCRs), shared his team’s progress in understanding receptor activation — and how that might guide drug development — at last week’s Flexner Discovery Lecture.
Mar. 29, 2018—Brian Kobilka, MD, who shared the 2012 Nobel Prize in Chemistry for his studies of G protein-coupled receptors (GPCRs), will deliver the next Flexner Discovery Lecture on April 5.
Feb. 15, 2018—Professor Linda Sealy has won the AAAS Mentor Award for Lifetime Achievement for her continued efforts to increase the number of underrepresented minorities in STEM Ph.D. programs.
Feb. 15, 2018—Eric Gouaux, PhD, whose work has helped reveal the molecular mechanisms by which nerve cells communicate, will deliver the next Flexner Discovery Lecture Thursday, Feb. 22.